Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Taysha granted 144,000 RSUs and an option to purchase 92,400 shares to a new employee as an employment inducement under Nasdaq Rule 5635(c)(4). The options have an exercise price of $5.78, equal to the closing price on the grant date, and vest over four years.
Key figures
- Rsus granted
- 144000
- Options granted
- 92400
- Option exercise price
- 5.78
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.